Investing Profile

Stacie Weninger

President, FBRI at F-Prime Capital Partners
Photo of Stacie Weninger, President at F-Prime Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
$100K - $10.0M
CompanyStageDateRound SizeTotal Raised
Neumora Therapeutics
Series AOct 2021$400M
Co-investors: Kristina Burow (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Alaa Halawa
Atalanta Therapeutics
Series AJan 2021$110M
Co-investors: Stephen Knight (F-Prime Capital Partners), Jessica Alston (F-Prime Capital Partners)
Denali Therapeutics
Series AMay 2015$220M
Co-investors: Robert Nelsen (ARCH Venture Partners), Doug Cole (Flagship Ventures)